Cell Therapeutics (CTIC) rockets 24%, although it's hard to work out why. The stock's been...

|About: CTI BioPharma Corp. (CTIC)|By:, SA News Editor

Cell Therapeutics (CTIC) rockets 24%, although it's hard to work out why. The stock's been fairly volatile over the past few months, and often seems to receive a big lift on news of Pixuvri, its treatment of aggressive non-Hodgkin B-cell lymphomas.